Fortress Biotech Inc. Preferred Stock 9.375% Perpetual

Fortress Biotech Inc. Preferred Stock 9.375% Perpetual is a type of preferred equity issued by Fortress Biotech Inc., a biopharmaceutical company engaged in the development and commercialization of prescription medications and therapeutic products. This financial instrument offers investors a fixed dividend yield of 9.375%, positioning it as a source of steady income. The "perpetual" nature of this preferred stock indicates it has no fixed maturity date, allowing dividends to be paid indefinitely as long as the issuing company remains solvent. Preferred stocks like this one often appeal to investors seeking stable returns, standing ahead of common equity in the capital structure during liquidation. Fortress Biotech operates across various sectors within the biotech industry, significantly impacting pharmaceutical innovation and therapeutic advancements. The preferred stock's distinctive high-dividend appeal underlines its importance in the market for investors prioritizing income over capital appreciation.